Latest Breaking News On - Nivolumab injection - Page 1 : comparemela.com

YANTAI, China, Dec. 27, 2023 /PRNewswire/ Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the

United statesDou changlinInternational agency for research on cancerDrug administrationBispecific engager technology platformPhage display technology platformTechnology platformWorld health organizationBoan biotechOrphan drug designationAntibody drug conjugateInternational agencyChief operating officerNivolumab injectionHuman antibody transgenic mouseBispecifict cell engager technology platform